Does BECAPLERMIN Cause Application site discolouration? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Application site discolouration have been filed in association with BECAPLERMIN. This represents 3.6% of all adverse event reports for BECAPLERMIN.
74
Reports of Application site discolouration with BECAPLERMIN
3.6%
of all BECAPLERMIN reports
0
Deaths
8
Hospitalizations
How Dangerous Is Application site discolouration From BECAPLERMIN?
Of the 74 reports, 8 (10.8%) required hospitalization.
Is Application site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BECAPLERMIN. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does BECAPLERMIN Cause?
Off label use (672)
Wound complication (448)
Application site pain (313)
Drug ineffective (191)
Inappropriate schedule of drug administration (169)
Osteomyelitis (162)
Incorrect drug administration duration (119)
Wound infection (114)
Application site erythema (102)
Toe amputation (102)
What Other Drugs Cause Application site discolouration?
SUMATRIPTAN (684)
BUPRENORPHINE (208)
INGENOL MEBUTATE (115)
MECHLORETHAMINE (101)
ESTRADIOL (89)
NICOTINE (87)
MINOXIDIL (76)
SALICYLIC ACID (76)
DICLOFENAC (67)
METHYLPHENIDATE (61)
Which BECAPLERMIN Alternatives Have Lower Application site discolouration Risk?
BECAPLERMIN vs BECLOMETHASONE
BECAPLERMIN vs BECLOMETHASONE DIPROPIONATE
BECAPLERMIN vs BEDAQUILINE
BECAPLERMIN vs BELIMUMAB
BECAPLERMIN vs BEMPEDOIC ACID